Karen J. Wilson

Insider Reports History

Entity
Individual
Location
C/O Jazz Pharmaceuticals Plc, 5 Th Fl, Waterloo Exchange, Waterloo Rd, Dublin L2 4, Ireland
Signature
/s/ Amy Garabedian, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karen J. Wilson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Serina Therapeutics, Inc. Director Stock Option (right to buy) 40K Jan 14, 2025 Direct
LAVA Therapeutics NV Director Common Shares (Right to Buy) 33.4K Feb 13, 2025 Direct
Vaxart, Inc. Director Stock Option (right to buy) 15.1K Jun 16, 2021 Direct
LAVA Therapeutics NV Director Common Shares 10K Jan 1, 2025 Direct
Elicio Therapeutics, Inc. Director Stock Option (Right to Buy) 4.1K Nov 21, 2024 Direct

Insider Reports Filed by Karen J. Wilson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LVTX LAVA Therapeutics NV Feb 13, 2025 1 $0 4 Feb 18, 2025 Director
SER Serina Therapeutics, Inc. Jan 14, 2025 1 $0 4 Jan 15, 2025 Director
SER Serina Therapeutics, Inc. Jan 14, 2025 0 $0 3 Jan 15, 2025 Director
LVTX LAVA Therapeutics NV Jan 1, 2025 0 $0 3 Jan 2, 2025 Director
ELTX Elicio Therapeutics, Inc. Nov 21, 2024 1 $0 4 Nov 25, 2024 Director
ELTX Elicio Therapeutics, Inc. Dec 28, 2023 1 $0 4 Dec 29, 2023 Director
ELTX Angion Biomedica Corp. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
VXRT Vaxart, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director